$MASI
MASIMO CORP

2014 Q3 Form 10-Q Financial Statement

#000093755614000138 Filed on October 29, 2014

View on sec.gov

Income Statement

Concept 2014 Q3 2013 Q4 2013 Q3
Revenue $144.1M $142.4M $131.4M
YoY Change 9.64% 7.77% 10.4%
Cost Of Revenue $47.89M $51.90M $43.97M
YoY Change 8.93% 15.33% 7.93%
Gross Profit $96.22M $90.54M $87.48M
YoY Change 10.0% 3.85% 11.68%
Gross Profit Margin 66.77% 63.56% 66.55%
Selling, General & Admin $62.06M $55.90M $53.09M
YoY Change 16.9% 8.33% 10.01%
% of Gross Profit 64.5% 61.74% 60.69%
Research & Development $14.21M $13.90M $13.65M
YoY Change 4.16% 4.51% 12.58%
% of Gross Profit 14.77% 15.35% 15.6%
Depreciation & Amortization $3.400M $2.900M $2.900M
YoY Change 17.24% 0.0% 16.0%
% of Gross Profit 3.53% 3.2% 3.32%
Operating Expenses $73.96M $69.90M $66.74M
YoY Change 10.82% 7.7% 10.52%
Operating Profit $22.27M $12.65M $20.74M
YoY Change 7.35% -43.19% 15.55%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net -$566.0K -$800.0K -$676.0K
YoY Change -16.27% -38.46% -174.12%
Pretax Income $21.70M $11.90M $20.07M
YoY Change 8.15% -43.33% 6.38%
Income Tax $5.568M $2.700M $4.581M
% Of Pretax Income 25.66% 22.69% 22.83%
Net Earnings $14.86M $9.313M $15.60M
YoY Change -4.74% -37.94% 13.11%
Net Earnings / Revenue 10.31% 6.54% 11.87%
Basic Earnings Per Share $0.28 $0.16 $0.28
Diluted Earnings Per Share $0.27 $0.16 $0.27
COMMON SHARES
Basic Shares Outstanding 53.99M shares 56.50M shares
Diluted Shares Outstanding 54.62M shares 57.40M shares

Balance Sheet

Concept 2014 Q3 2013 Q4 2013 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $119.0M $95.50M $91.70M
YoY Change 29.77% 33.38% -18.85%
Cash & Equivalents $119.0M $95.47M $91.72M
Short-Term Investments
Other Short-Term Assets $5.429M $19.38M $2.928M
YoY Change 85.42% 397.54% -17.61%
Inventory $62.83M $56.81M $59.46M
Prepaid Expenses $11.22M $9.243M $18.86M
Receivables $73.24M $76.76M $70.17M
Other Receivables $6.800M $7.300M $6.800M
Total Short-Term Assets $299.6M $271.8M $261.9M
YoY Change 14.39% 23.91% 0.67%
LONG-TERM ASSETS
Property, Plant & Equipment $87.62M $24.87M $24.94M
YoY Change 251.39% 3.94% 8.28%
Goodwill $21.75M $22.79M $22.96M
YoY Change -5.26% -0.14% 0.94%
Intangibles $28.19M $28.10M $28.03M
YoY Change 0.55% 2.71% 2.73%
Long-Term Investments
YoY Change
Other Assets $7.552M $6.822M $7.190M
YoY Change 5.03% -14.96% -4.27%
Total Long-Term Assets $232.8M $166.9M $165.8M
YoY Change 40.41% 7.44% 10.99%
TOTAL ASSETS
Total Short-Term Assets $299.6M $271.8M $261.9M
Total Long-Term Assets $232.8M $166.9M $165.8M
Total Assets $532.5M $438.7M $427.8M
YoY Change 24.48% 17.08% 4.43%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $28.99M $28.00M $38.13M
YoY Change -23.98% 3.59% 46.53%
Accrued Expenses $31.51M $23.03M $15.94M
YoY Change 97.62% 38.32% -3.84%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $125.1M $100.0K $100.0K
YoY Change 125000.0% 0.0% 0.0%
Total Short-Term Liabilities $240.2M $103.8M $103.4M
YoY Change 132.3% 15.92% 22.36%
LONG-TERM LIABILITIES
Long-Term Debt $100.0K $200.0K $200.0K
YoY Change -50.0% 100.0% 100.0%
Other Long-Term Liabilities $7.544M $7.680M $9.683M
YoY Change -22.09% -12.91% -3.84%
Total Long-Term Liabilities $7.544M $7.680M $9.683M
YoY Change -22.09% -12.91% -3.84%
TOTAL LIABILITIES
Total Short-Term Liabilities $240.2M $103.8M $103.4M
Total Long-Term Liabilities $7.544M $7.680M $9.683M
Total Liabilities $248.4M $112.3M $113.9M
YoY Change 118.11% 13.4% 19.43%
SHAREHOLDERS EQUITY
Retained Earnings $184.0M $132.7M $123.4M
YoY Change 49.11% 78.51% 5.83%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $185.3M $83.45M $83.45M
YoY Change 122.07% 31.09% 31.09%
Treasury Stock Shares 8.583M shares 4.156M shares 4.156M shares
Shareholders Equity $282.9M $326.5M $313.8M
YoY Change
Total Liabilities & Shareholders Equity $532.5M $438.7M $427.8M
YoY Change 24.48% 17.08% 4.43%

Cashflow Statement

Concept 2014 Q3 2013 Q4 2013 Q3
OPERATING ACTIVITIES
Net Income $14.86M $9.313M $15.60M
YoY Change -4.74% -37.94% 13.11%
Depreciation, Depletion And Amortization $3.400M $2.900M $2.900M
YoY Change 17.24% 0.0% 16.0%
Cash From Operating Activities $28.00M $6.100M $15.80M
YoY Change 77.22% -66.85% -38.76%
INVESTING ACTIVITIES
Capital Expenditures -$5.600M -$3.100M -$3.800M
YoY Change 47.37% -18.42% -17.39%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities -$5.600M -$3.100M -$3.800M
YoY Change 47.37% -18.42% -89.11%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 800.0K 1.000M 600.0K
YoY Change 33.33% -101.77% 20.0%
NET CHANGE
Cash From Operating Activities 28.00M 6.100M 15.80M
Cash From Investing Activities -5.600M -3.100M -3.800M
Cash From Financing Activities 800.0K 1.000M 600.0K
Net Change In Cash 23.20M 4.000M 12.60M
YoY Change 84.13% -109.52% -246.51%
FREE CASH FLOW
Cash From Operating Activities $28.00M $6.100M $15.80M
Capital Expenditures -$5.600M -$3.100M -$3.800M
Free Cash Flow $33.60M $9.200M $19.60M
YoY Change 71.43% -58.56% -35.53%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
masi Long Term Sales Agreement Warranty Maximum
LongTermSalesAgreementWarrantyMaximum
P6Y
masi Long Term Sales Agreement Warranty Minimum
LongTermSalesAgreementWarrantyMinimum
P3Y
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9000000 USD
CY2014Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
31507000 USD
CY2013Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
23028000 USD
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
49415000 USD
CY2014Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
56029000 USD
CY2014Q3 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
584000 USD
CY2013Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
3995000 USD
CY2013Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
273129000 USD
CY2014Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
283577000 USD
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
28004000 USD
CY2014Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
28988000 USD
CY2013Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
76759000 USD
CY2014Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
73235000 USD
CY2014Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
3042000 USD
CY2013Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
2406000 USD
CY2014Q3 us-gaap Accrued Rent Current And Noncurrent
AccruedRentCurrentAndNoncurrent
500000 USD
CY2013Q4 us-gaap Accrued Rent Current And Noncurrent
AccruedRentCurrentAndNoncurrent
700000 USD
CY2014Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2600000 USD
CY2013Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2600000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7800000 USD
CY2013Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1833000 USD
CY2014Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2134000 USD
CY2013Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
800000 USD
CY2014Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1000000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2700000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2700000 USD
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1500000 shares
CY2013Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5700000 shares
CY2014Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3100000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7200000 shares
CY2013Q4 us-gaap Assets
Assets
438662000 USD
CY2014Q3 us-gaap Assets
Assets
532468000 USD
CY2014Q3 us-gaap Assets Current
AssetsCurrent
299620000 USD
CY2013Q4 us-gaap Assets Current
AssetsCurrent
271798000 USD
CY2014Q3 us-gaap Capital Leases Future Minimum Payments Due
CapitalLeasesFutureMinimumPaymentsDue
249000 USD
CY2014Q3 us-gaap Capital Leases Future Minimum Payments Due In Five Years
CapitalLeasesFutureMinimumPaymentsDueInFiveYears
0 USD
CY2014Q3 us-gaap Capital Leases Future Minimum Payments Due In Four Years
CapitalLeasesFutureMinimumPaymentsDueInFourYears
75000 USD
CY2014Q3 us-gaap Capital Leases Future Minimum Payments Due In Three Years
CapitalLeasesFutureMinimumPaymentsDueInThreeYears
80000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-84000 USD
CY2013Q4 us-gaap Cash
Cash
67700000 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
95466000 USD
CY2014Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
118988000 USD
CY2013Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
91717000 USD
CY2014Q3 us-gaap Capital Leases Future Minimum Payments Due In Two Years
CapitalLeasesFutureMinimumPaymentsDueInTwoYears
87000 USD
CY2014Q3 us-gaap Capital Leases Future Minimum Payments Due Thereafter
CapitalLeasesFutureMinimumPaymentsDueThereafter
0 USD
CY2014Q3 us-gaap Capital Leases Future Minimum Payments Remainder Of Fiscal Year
CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear
7000 USD
CY2014Q3 us-gaap Cash
Cash
90900000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
71554000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
20163000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
23522000 USD
CY2013Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
27800000 USD
CY2014Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
28100000 USD
CY2014Q3 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
3000000 USD
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
56623000 shares
CY2014Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
52412000 shares
CY2014Q3 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
52000 USD
CY2013Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
57000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
49951000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
47886000 USD
CY2014Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
13162000 USD
CY2013Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
17144000 USD
CY2013Q3 us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
1.000
us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
1.000
CY2014Q3 us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
1.000
us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
1.000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
6306000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-2000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2773000 USD
CY2014Q3 us-gaap Contractual Obligation
ContractualObligation
17772000 USD
CY2014Q3 us-gaap Contractual Obligation Due After Fifth Year
ContractualObligationDueAfterFifthYear
2895000 USD
CY2014Q3 us-gaap Contractual Obligation Due In Fifth Year
ContractualObligationDueInFifthYear
1922000 USD
CY2014Q3 us-gaap Contractual Obligation Due In Fourth Year
ContractualObligationDueInFourthYear
2578000 USD
CY2014Q3 us-gaap Contractual Obligation Due In Second Year
ContractualObligationDueInSecondYear
4777000 USD
CY2014Q3 us-gaap Contractual Obligation Due In Third Year
ContractualObligationDueInThirdYear
4069000 USD
CY2014Q3 us-gaap Contractual Obligation Future Minimum Payments Due Remainder Of Fiscal Year
ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear
1531000 USD
CY2014Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
47894000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
143236000 USD
CY2013Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
43968000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
136519000 USD
us-gaap Debt Issuance Costs
DebtIssuanceCosts
0 USD
us-gaap Debt Issuance Costs
DebtIssuanceCosts
-143000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1687000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
2926000 USD
CY2013Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
20755000 USD
CY2014Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
21274000 USD
CY2014Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
492000 USD
CY2013Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
566000 USD
CY2013Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
19636000 USD
CY2014Q3 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
16698000 USD
CY2014Q3 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
22513000 USD
CY2013Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
22565000 USD
CY2014Q3 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
600000 USD
us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
1800000 USD
us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
1200000 USD
CY2013Q3 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
400000 USD
us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
0.03
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8459000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9481000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
558000 USD
CY2013Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.28
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.86
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.92
CY2014Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.28
CY2013Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.27
CY2014Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.27
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.85
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.91
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
764000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-2326000 USD
CY2013Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
29486000 USD
CY2014Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
30287000 USD
CY2014Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
23400000 USD
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P5Y3M18D
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
-759000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
-74000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
-74000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
-759000 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
9814000 USD
CY2014Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
12110000 USD
CY2014Q3 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
15328000 USD
CY2014Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
1615000 USD
CY2014Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
2470000 USD
CY2014Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
2645000 USD
CY2014Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
2746000 USD
CY2014Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
3383000 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
37918000 USD
CY2014Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
40297000 USD
CY2014Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
28187000 USD
CY2013Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4581000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
17288000 USD
CY2013Q4 us-gaap Goodwill
Goodwill
22793000 USD
CY2014Q3 us-gaap Goodwill
Goodwill
21752000 USD
us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 USD
CY2013Q3 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 USD
CY2014Q3 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 USD
us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
28104000 USD
us-gaap Fiscal Period
FiscalPeriod
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:17px;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Fiscal Periods</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company follows a 52-53 week fiscal year that ends on the Saturday closest to December 31. A 52 week year includes four 13 fiscal week quarters, while a 53 week fiscal year includes three 13 fiscal week quarters and one 14 fiscal week quarter. The last 53 week fiscal year was fiscal year 2008. Fiscal year 2014 is a 53 week fiscal year. All references to years in these notes to condensed consolidated financial statements are fiscal years unless otherwise noted.</font></div></div>
CY2013Q3 us-gaap Gross Profit
GrossProfit
87479000 USD
us-gaap Gross Profit
GrossProfit
268292000 USD
CY2014Q3 us-gaap Gross Profit
GrossProfit
96224000 USD
us-gaap Gross Profit
GrossProfit
281620000 USD
CY2014Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
21702000 USD
CY2013Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
20067000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
70823000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
63824000 USD
CY2014Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5568000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
18246000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
11091000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1609000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-3198000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-1217000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
5446000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-673000 USD
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
9100000 USD
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
3580000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
354000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
445000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
3544000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
1181000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
12074000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
3365000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-1777000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-136000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-417000 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
1928000 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
3870000 USD
us-gaap Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidTaxes
685000 USD
us-gaap Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidTaxes
6434000 USD
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
860000 shares
CY2014Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
630000 shares
CY2013Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
903000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
779000 shares
CY2013Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
28104000 USD
CY2014Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
28187000 USD
CY2013Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
23745000 USD
CY2014Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
27995000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
7.85
CY2014Q3 us-gaap Inventory Net
InventoryNet
62834000 USD
CY2013Q4 us-gaap Inventory Net
InventoryNet
56813000 USD
CY2014Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
28466000 USD
CY2013Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
26758000 USD
CY2013Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
6310000 USD
CY2014Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
6373000 USD
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
3900000 USD
CY2013Q3 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
1300000 USD
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
4800000 USD
CY2014Q3 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
1600000 USD
us-gaap Legal Fees
LegalFees
-10331000 USD
CY2014Q3 us-gaap Legal Fees
LegalFees
-2321000 USD
us-gaap Legal Fees
LegalFees
0 USD
CY2014Q3 us-gaap Liabilities
Liabilities
248365000 USD
CY2013Q4 us-gaap Liabilities
Liabilities
112261000 USD
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
438662000 USD
CY2014Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
532468000 USD
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
103790000 USD
CY2014Q3 us-gaap Liabilities Current
LiabilitiesCurrent
240181000 USD
CY2013Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
225000 USD
CY2014Q3 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
148000 USD
CY2014Q3 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
125083000 USD
CY2013Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
111000 USD
CY2014Q1 us-gaap Loss Contingency Accrual Carrying Value Period Increase Decrease
LossContingencyAccrualCarryingValuePeriodIncreaseDecrease
-8000000 USD
CY2013Q4 us-gaap Minority Interest
MinorityInterest
-68000 USD
CY2014Q3 us-gaap Minority Interest
MinorityInterest
1176000 USD
CY2013Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
1800000 USD
CY2014Q3 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
1100000 USD
us-gaap Nature Of Operations
NatureOfOperations
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;"> Description of the Company</font></div><div style="line-height:120%;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Masimo Corporation (Masimo or the Company) is a global medical technology company that develops, manufactures and markets noninvasive patient monitoring products. The Company&#8217;s mission is to improve patient outcomes and reduce cost of care by taking noninvasive monitoring to new sites and applications. The Company invented Masimo Signal Extraction Technology</font><font style="font-family:inherit;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">&#174; </sup></font><font style="font-family:inherit;font-size:10pt;">(SET</font><font style="font-family:inherit;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">), which provides the capabilities of Measure-Through-Motion and Low-Perfusion pulse oximetry to address the primary limitations of conventional pulse oximetry. The Company has also developed Masimo rainbow</font><font style="font-family:inherit;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> SET</font><font style="font-family:inherit;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> products which monitor multiple blood measurements, including oxygen content, carboxyhemoglobin, methemoglobin and hemoglobin. Additional rainbow</font><font style="font-family:inherit;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> SET</font><font style="font-family:inherit;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> measurements that assist clinicians are PVI</font><font style="font-family:inherit;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">, RRa</font><font style="font-family:inherit;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">, SpfO</font><font style="font-family:inherit;font-size:8pt;"><sub style="vertical-align:bottom;line-height:120%;font-size:5pt">2</sub></font><font style="font-family:inherit;font-size:7.5pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt">&#8482;</sup></font><font style="font-family:inherit;font-size:10pt;">, Halo Index</font><font style="font-family:inherit;font-size:7.5pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt">&#8482;</sup></font><font style="font-family:inherit;font-size:10pt;"> and In Vivo Adjustment</font><font style="font-family:inherit;font-size:7.5pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt">&#8482;</sup></font><font style="font-family:inherit;font-size:10pt;">. The Company develops, manufactures and markets a family of patient monitoring solutions which incorporate a monitor or circuit board and sensors, including proprietary single-patient use, reusable and resposable sensors, and cables. The Company sells to hospitals and the alternate care market through its direct sales force and distributors, and markets its circuit boards containing the Company&#8217;s proprietary algorithm and software architecture to original equipment manufacturer (OEM) partners.</font></div></div>
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
28651000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-18915000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-9896000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-69626000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
66823000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
48210000 USD
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
15602000 USD
us-gaap Net Income Loss
NetIncomeLoss
51297000 USD
us-gaap Net Income Loss
NetIncomeLoss
49068000 USD
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
14863000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-2532000 USD
CY2013Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-116000 USD
CY2014Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1271000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1280000 USD
us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
36000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-43000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3240000 USD
CY2013Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-676000 USD
CY2014Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-566000 USD
us-gaap Operating Expenses
OperatingExpenses
201228000 USD
us-gaap Operating Expenses
OperatingExpenses
210754000 USD
CY2013Q3 us-gaap Operating Expenses
OperatingExpenses
66736000 USD
CY2014Q3 us-gaap Operating Expenses
OperatingExpenses
73956000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
70866000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
67064000 USD
CY2014Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
22268000 USD
CY2013Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
20743000 USD
CY2014Q3 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
17523000 USD
CY2014Q3 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
1922000 USD
CY2014Q3 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
2503000 USD
CY2014Q3 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
3989000 USD
CY2014Q3 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
4690000 USD
CY2014Q3 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
2895000 USD
CY2014Q3 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
1524000 USD
CY2013Q4 us-gaap Other Assets Current
OtherAssetsCurrent
2841000 USD
CY2014Q3 us-gaap Other Assets Current
OtherAssetsCurrent
5429000 USD
CY2014Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
7552000 USD
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6822000 USD
CY2014Q3 us-gaap Other Commitment
OtherCommitment
400000 USD
CY2013Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1542000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-3411000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
883000 USD
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y6M
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y7M6D
CY2014Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1701000 USD
CY2014Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
7544000 USD
CY2013Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
7680000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
98676000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
19790000 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
2779000 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
2986000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
66847000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6910000 USD
CY2014Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2014Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2013Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q3 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0 USD
CY2013Q4 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0 USD
CY2013Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
9243000 USD
CY2014Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
11215000 USD
CY2013Q4 us-gaap Prepaid Taxes
PrepaidTaxes
3740000 USD
CY2014Q3 us-gaap Prepaid Taxes
PrepaidTaxes
4421000 USD
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:17px;text-align:left;padding-left:18px;font-size:12pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Reclassifications</font><font style="font-family:inherit;font-size:12pt;"> </font></div><div style="line-height:120%;padding-top:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain amounts in the condensed consolidated financial statements for prior periods have been reclassified to conform to the current period presentation. </font></div></div>
us-gaap Proceeds From Payments To Minority Shareholders
ProceedsFromPaymentsToMinorityShareholders
-38000 USD
us-gaap Proceeds From Payments To Minority Shareholders
ProceedsFromPaymentsToMinorityShareholders
0 USD
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
0 USD
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
125000000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2687000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1746000 USD
CY2014Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
1058000 USD
CY2012Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
838000 USD
CY2013Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
1135000 USD
CY2013Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
1161000 USD
us-gaap Product Warranty Accrual Period Increase Decrease
ProductWarrantyAccrualPeriodIncreaseDecrease
1143000 USD
us-gaap Product Warranty Accrual Period Increase Decrease
ProductWarrantyAccrualPeriodIncreaseDecrease
684000 USD
us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
164000 USD
us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
25000 USD
us-gaap Product Warranty Expense
ProductWarrantyExpense
812000 USD
us-gaap Product Warranty Expense
ProductWarrantyExpense
1010000 USD
CY2014Q3 us-gaap Profit Loss
ProfitLoss
16134000 USD
CY2013Q3 us-gaap Profit Loss
ProfitLoss
15486000 USD
us-gaap Profit Loss
ProfitLoss
46536000 USD
us-gaap Profit Loss
ProfitLoss
52577000 USD
CY2013Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
74281000 USD
CY2014Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
143647000 USD
CY2014Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
87618000 USD
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
24866000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
532000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
211000 USD
CY2014Q3 us-gaap Purchase Obligation
PurchaseObligation
78000000 USD
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
105000 USD
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
112000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
41552000 USD
CY2013Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13646000 USD
CY2014Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14213000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
41692000 USD
CY2014Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
184039000 USD
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
132742000 USD
us-gaap Revenues
Revenues
424856000 USD
CY2013Q3 us-gaap Revenues
Revenues
131447000 USD
CY2014Q3 us-gaap Revenues
Revenues
144118000 USD
us-gaap Revenues
Revenues
404811000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
402868000 USD
CY2014Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
137142000 USD
CY2013Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
124522000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
382725000 USD
CY2013Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
53090000 USD
CY2014Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
62064000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
159536000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
179533000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
7784000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
9020000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.396
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.331
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.331
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.377
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.362
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.322
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.362
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.318
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.016
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.016
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.018
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.018
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.007
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.015
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.007
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.014
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
5710000 shares
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
5750000 shares
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
23.27
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
3200000 USD
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
600000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
256000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
1777000 shares
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
8.41
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
6.79
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
7.52
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
16100000 USD
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
10216000 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
8911000 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
22.76
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
23.31
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
14600000 USD
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
12.37
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
24.56
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
24.92
CY2013Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y6M
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y29D
CY2014Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y29D
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
216000 shares
CY2013Q1 us-gaap Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
6000000.0 shares
CY2014Q3 us-gaap Stockholders Equity
StockholdersEquity
282927000 USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
326469000 USD
CY2014Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
284103000 USD
CY2013Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
326401000 USD
CY2014Q3 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
21.95
us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
23.01
CY2013Q3 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
19.79
CY2013Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
4156000 shares
CY2014Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
8583000 shares
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
1000000 shares
CY2013Q3 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
0 shares
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
4400000.0 shares
CY2014Q3 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
2400000.0 shares
CY2013Q4 us-gaap Treasury Stock Value
TreasuryStockValue
83454000 USD
CY2014Q3 us-gaap Treasury Stock Value
TreasuryStockValue
185325000 USD
CY2013Q3 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
19800000 USD
CY2014Q3 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
52700000 USD
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
101900000 USD
CY2014Q3 us-gaap Us Government Securities At Carrying Value
USGovernmentSecuritiesAtCarryingValue
27000000 USD
CY2013Q4 us-gaap Us Government Securities At Carrying Value
USGovernmentSecuritiesAtCarryingValue
26000000 USD
CY2014Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
7200000 USD
CY2014Q3 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
6100000 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:17px;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company prepares its financial statements in conformity with GAAP, which requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Significant estimates include the determination of accounts receivable allowances, inventory reserves, warranty reserves, rebate accruals, valuation of the Company&#8217;s stock options, goodwill valuation, deferred taxes and any associated valuation allowances, distributor channel inventory, royalty revenues, deferred revenue, uncertain income tax positions, property taxes, litigation costs and related accruals. Actual results could differ from such estimates.</font></div><div style="line-height:120%;padding-top:17px;text-align:left;padding-left:18px;font-size:12pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"></font></div></div>
CY2013Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
57404000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
56381000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
57506000 shares
CY2014Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
54618000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56727000 shares
CY2014Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
53988000 shares
CY2013Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56501000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
55521000 shares
CY2014Q2 masi Cash Equivalents Maximum Maturity Period
CashEquivalentsMaximumMaturityPeriod
Three months or less
CY2013Q4 masi Deferred Cost Of Goods Sold
DeferredCostOfGoodsSold
61714000 USD
CY2014Q3 masi Deferred Cost Of Goods Sold
DeferredCostOfGoodsSold
65226000 USD
masi Income Tax Benefit From Exercise Of Stock Options Granted
IncomeTaxBenefitFromExerciseOfStockOptionsGranted
49000 USD
masi Income Tax Benefit From Exercise Of Stock Options Granted
IncomeTaxBenefitFromExerciseOfStockOptionsGranted
595000 USD
masi Increase Decrease In Royalties Receivable
IncreaseDecreaseInRoyaltiesReceivable
-330000 USD
masi Increase Decrease In Royalties Receivable
IncreaseDecreaseInRoyaltiesReceivable
-500000 USD
masi Initial Term Of Executive Employment Agreement
InitialTermOfExecutiveEmploymentAgreement
P3Y
masi Number Of Days After Which Royalty Report And Payment Is Received
NumberOfDaysAfterWhichRoyaltyReportAndPaymentIsReceived
P60D
CY2011Q3 masi Numberof Former Sales Representatives
NumberofFormerSalesRepresentatives
2 sales_representatives
CY2014Q1 masi Numberof Participantsinthe Surfactant Positive Pressureand Oxygenation Randomized Trial
NumberofParticipantsintheSurfactantPositivePressureandOxygenationRandomizedTrial
2 participant
masi Percentage Of Revenue One Customer
PercentageOfRevenueOneCustomer
0.13
masi Percentage Of Revenue One Customer
PercentageOfRevenueOneCustomer
0.14
CY2014Q3 masi Percentage Of Revenue One Customer
PercentageOfRevenueOneCustomer
0.14
CY2013Q3 masi Percentage Of Revenue One Customer
PercentageOfRevenueOneCustomer
0.14
CY2013Q3 masi Percentage Of Revenue Two Customer
PercentageOfRevenueTwoCustomer
0.11
CY2014Q3 masi Percentage Of Revenue Two Customer
PercentageOfRevenueTwoCustomer
0.12
masi Percentage Of Revenue Two Customer
PercentageOfRevenueTwoCustomer
0.11
masi Percentage Of Revenue Two Customer
PercentageOfRevenueTwoCustomer
0.11
masi Rate Of Royalty Agreed To Be Paid
RateOfRoyaltyAgreedToBePaid
0.0775
CY2013Q4 masi Royalties Receivables
RoyaltiesReceivables
7300000 USD
CY2013Q3 masi Royalty
Royalty
6925000 USD
masi Royalty
Royalty
21988000 USD
masi Royalty
Royalty
22086000 USD
CY2014Q3 masi Royalty
Royalty
6976000 USD
masi Royalty Rate Percentage
RoyaltyRatePercentage
0.0775
CY2014Q3 masi Royalty Receivable
RoyaltyReceivable
6800000 USD
masi Royalty Revenue Numberof Days Royalty Revenueis Adjusted Subsequentto Quarter End
RoyaltyRevenueNumberofDaysRoyaltyRevenueisAdjustedSubsequenttoQuarterEnd
P60D
CY2014Q3 masi Severance Plan Participation Agreements
SeverancePlanParticipationAgreements
6 Agreement
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--01-03
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
dei Document Period End Date
DocumentPeriodEndDate
2014-09-27
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0000937556
CY2014Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
52411582 shares
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
MASIMO CORP
dei Trading Symbol
TradingSymbol
MASI

Files In Submission

Name View Source Status
0000937556-14-000138-index-headers.html Edgar Link pending
0000937556-14-000138-index.html Edgar Link pending
0000937556-14-000138.txt Edgar Link pending
0000937556-14-000138-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
masi-20140927.xml Edgar Link completed
masi-20140927.xsd Edgar Link pending
masi-20140927x10q.htm Edgar Link pending
masi-20140927x10qex121.htm Edgar Link pending
masi-20140927x10qex311.htm Edgar Link pending
masi-20140927x10qex312.htm Edgar Link pending
masi-20140927x10qex321.htm Edgar Link pending
masi-20140927_cal.xml Edgar Link unprocessable
masi-20140927_def.xml Edgar Link unprocessable
masi-20140927_lab.xml Edgar Link unprocessable
masi-20140927_pre.xml Edgar Link unprocessable
masimologo300-3q.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending